Jasper Therapeutics (NASDAQ:JSPR) Stock, Quote.Headers.trade-ideas

Jasper Therapeutics

Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.

xr:d:DAFl_HSvCpE:2,j:6755793051000407071,t:23061612

News

Intraday Update

Markets

Movers

Trading Ideas

ALUR

APLD

ASNS

BILI

DMTK

ESPR

FEMY

GRDI

HIMX

MicroCloud Hologram Inc. - Ordinary Shares

HOLO

HROW

IBRX

Jasper Therapeutics, Inc. - Class A Common Stock

JSPR

KAVL

LOBO

LRHC

MBIO

MGOL

MOLN

NKLA

NLSP

NNVC

NYAX

OCUL

PACK

PRST

RELI

SLNH

SMCI

SONN

SRFM

SVMH

TBLT

Tempest Therapeutics, Inc. - Common Stock

TPST

TRVN

VNDA

ZAPP

Why Jabil Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Thursday&#39;s Mid-Day Session

Spirit_Airlines-Wikimedia Commons

ALLG

AMGN

BOWL

CRML

CVAC

EYPT

GERN

IART

SAVE

UNIT

Spirit Airlines Posts Weak Results, Joins Integra LifeSciences, Bowlero And Other Big Stocks Moving Lower On Monday

Long Ideas

Insider Trades

CIZN

Although U.S. stocks closed mixed on Friday, there were a few notable insider trades.

Over $15M Bet On Aon? Check Out These 3 Stocks Insiders Are Buying

Jasper Therapeutics Inc

Financial giants have made a conspicuous bullish move on Unity Software. Our analysis of options history for Unity Software (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/U#NYSE">U</a>) revealed 24 unusual trades.
Delving into the details, we found 50% of traders were bullish, while 33% showed bearish tendencies. Out of all the trades we spotted, 2 were puts, with a value of $73,625, and 22 were calls, valued at $2,431,788.
<h3>Predicted Price Range</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $20.0 to $60.0 for Unity Software over the recent three months. 
<h3>Volume &amp; Open Interest Development</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Unity Software's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Unity Software's significant trades, within a strike price range of $20.0 to $60.0, over the past month.
<h3>Unity Software Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1727283660_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>U</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>10/18/24</td>
<td>$3.55</td>
<td>$3.2</td>
<td>$3.4</td>
<td>$20.00</td>
<td>$1.7M</td>
<td>13.5K</td>
<td>5.2K</td>
</tr>
<tr>
<td>U</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$3.15</td>
<td>$3.1</td>
<td>$3.1</td>
<td>$23.00</td>
<td>$55.8K</td>
<td>3.5K</td>
<td>254</td>
</tr>
<tr>
<td>U</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$5.3</td>
<td>$5.25</td>
<td>$5.25</td>
<td>$20.00</td>
<td>$54.6K</td>
<td>20.0K</td>
<td>5.5K</td>
</tr>
<tr>
<td>U</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>11/15/24</td>
<td>$2.88</td>
<td>$2.79</td>
<td>$2.88</td>
<td>$23.00</td>
<td>$53.2K</td>
<td>5.2K</td>
<td>900</td>
</tr>
<tr>
<td>U</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>11/15/24</td>
<td>$2.66</td>
<td>$2.56</td>
<td>$2.61</td>
<td>$23.00</td>
<td>$48.2K</td>
<td>5.2K</td>
<td>1.2K</td>
</tr>
</tbody>
</table>

<h3>About Unity Software</h3>
Unity Software Inc provides a software platform for creating and operating interactive, real-time 3D content. The platform can be used to create, run, and monetize interactive, real-time 2D and 3D content for mobile phones, tablets, PCs, consoles, and augmented and virtual reality devices. The business is spread across the United States, Greater China, EMEA, APAC, and Other Americas, of which key revenue is derived from the EMEA region. The products are used in the gaming industry, architecture and construction sector, animation industry, and designing sector.
In light of the recent options history for Unity Software, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Unity Software's Current Market Status</h3>
<ul>
<li>With a trading volume of 9,822,277, the price of U is down by -2.7%, reaching $22.57.</li>
<li>Current RSI values indicate that the stock is may be overbought.</li>
<li>Next earnings report is scheduled for 43 days from now.</li>
</ul>
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>.
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Unity Software with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

Options

Behind the Scenes of Unity Software's Latest Options Trends

Whales with a lot of money to spend have taken a noticeably bullish stance on IBM.
Looking at options history for IBM (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IBM#NYSE">IBM</a>) we detected 17 trades.
If we consider the specifics of each trade, it is accurate to state that 52% of the investors opened trades with bullish expectations and 11% with bearish.
From the overall spotted trades, 3 are puts, for a total amount of $140,473 and 14, calls, for a total amount of $770,416.
<h3>Projected Price Targets</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $175.0 to $240.0 for IBM over the recent three months. 
<h3>Volume &amp; Open Interest Development</h3>
In today's trading context, the average open interest for options of IBM stands at 1456.17, with a total volume reaching 1,828.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in IBM, situated within the strike price corridor from $175.0 to $240.0, throughout the last 30 days.
<h3>IBM Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1727283655_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>IBM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$24.4</td>
<td>$24.25</td>
<td>$24.4</td>
<td>$200.00</td>
<td>$197.6K</td>
<td>10</td>
<td style="text-align: right;">201</td>
</tr>
<tr>
<td>IBM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>10/25/24</td>
<td>$8.75</td>
<td>$8.3</td>
<td>$8.53</td>
<td>$220.00</td>
<td>$83.6K</td>
<td>551</td>
<td style="text-align: right;">282</td>
</tr>
<tr>
<td>IBM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$39.15</td>
<td>$38.25</td>
<td>$38.72</td>
<td>$190.00</td>
<td>$62.1K</td>
<td>594</td>
<td style="text-align: right;">16</td>
</tr>
<tr>
<td>IBM</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$15.3</td>
<td>$15.1</td>
<td>$15.21</td>
<td>$230.00</td>
<td>$61.3K</td>
<td>15</td>
<td style="text-align: right;">149</td>
</tr>
<tr>
<td>IBM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$8.3</td>
<td>$8.25</td>
<td>$8.3</td>
<td>$240.00</td>
<td>$53.9K</td>
<td>2.5K</td>
<td style="text-align: right;">71</td>
</tr>
</tbody>
</table>

<h3>About IBM</h3>
IBM looks to be a part of every aspect of an enterprise's IT needs. The company primarily sells software, IT services, consulting, and hardware. IBM operates in 175 countries and employs approximately 350,000 people. The company has a robust roster of 80,000 business partners to service 5,200 clients, which includes 95% of all Fortune 500. While IBM is a B2B company, IBM's outward impact is substantial. For example, IBM manages 90% of all credit card transactions globally and is responsible for 50% of all wireless connections in the world.
Having examined the options trading patterns of IBM, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>IBM's Current Market Status</h3>
<ul>
<li>With a trading volume of 869,227, the price of IBM is up by 0.02%, reaching $221.01.</li>
<li>Current RSI values indicate that the stock is may be overbought.</li>
<li>Next earnings report is scheduled for 28 days from now.</li>
</ul>
<h3>What Analysts Are Saying About IBM</h3>
A total of 2 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $192.5.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from UBS has decided to maintain their Sell rating on IBM, which currently sits at a price target of $145. 
&#x2A; An analyst from Evercore ISI Group persists with their Outperform rating on IBM, maintaining a target price of $240. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest IBM options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

Check Out What Whales Are Doing With IBM

Investors with a lot of money to spend have taken a bullish stance on Colgate-Palmolive (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CL#NYSE">CL</a>).
And retail traders should know.
We noticed this today when the positions showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with CL, it often means somebody knows something is about to happen.
Today, Benzinga's options scanner spotted 10 options trades for Colgate-Palmolive.
This isn't normal.
The overall sentiment of these big-money traders is split between 90% bullish and 10%, bearish.
Out of all of the options we uncovered, there was 1 put, for a total amount of $32,560, and 9, calls, for a total amount of $794,180.
<h3>Expected Price Movements</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $97.5 to $110.0 for Colgate-Palmolive over the recent three months. 
<h3>Insights into Volume &amp; Open Interest</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Colgate-Palmolive's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Colgate-Palmolive's significant trades, within a strike price range of $97.5 to $110.0, over the past month.
<h3>Colgate-Palmolive Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1727283650_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th style="text-align: right;">Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>CL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>10/11/24</td>
<td>$5.5</td>
<td>$5.4</td>
<td>$5.5</td>
<td>$99.00</td>
<td>$110.0K</td>
<td style="text-align: right;">1</td>
<td>1.4K</td>
</tr>
<tr>
<td>CL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>10/11/24</td>
<td>$5.5</td>
<td>$5.2</td>
<td>$5.5</td>
<td>$99.00</td>
<td>$110.0K</td>
<td style="text-align: right;">1</td>
<td>1.0K</td>
</tr>
<tr>
<td>CL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>10/11/24</td>
<td>$5.5</td>
<td>$5.4</td>
<td>$5.5</td>
<td>$99.00</td>
<td>$109.8K</td>
<td style="text-align: right;">1</td>
<td>1.6K</td>
</tr>
<tr>
<td>CL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>10/11/24</td>
<td>$5.5</td>
<td>$5.4</td>
<td>$5.5</td>
<td>$99.00</td>
<td>$109.8K</td>
<td style="text-align: right;">1</td>
<td>1.2K</td>
</tr>
<tr>
<td>CL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>10/11/24</td>
<td>$5.4</td>
<td>$5.2</td>
<td>$5.4</td>
<td>$99.00</td>
<td>$107.8K</td>
<td style="text-align: right;">1</td>
<td>600</td>
</tr>
</tbody>
</table>

<h3>About Colgate-Palmolive</h3>
Since its founding in 1806, Colgate-Palmolive has grown to become a leading player in the household and personal care arena. In addition to its namesake oral care line (which accounts for more than 40% of its total sales), the firm manufactures shampoos, shower gels, deodorants, and homecare products that are sold in over 200 countries. International sales account for about 70% of its total business, including approximately 45% from emerging regions. It also owns specialty pet food maker Hill's (around one fifth of sales), which primarily sells its products through veterinarians and specialty pet retailers.
In light of the recent options history for Colgate-Palmolive, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Colgate-Palmolive's Current Market Status</h3>
<ul>
<li>Trading volume stands at 845,127, with CL's price down by -0.07%, positioned at $103.72.</li>
<li>RSI indicators show the stock to be is currently neutral between overbought and oversold.</li>
<li>Earnings announcement expected in 30 days.</li>
</ul>
<h3>Expert Opinions on Colgate-Palmolive</h3>
4 market experts have recently issued ratings for this stock, with a consensus target price of $113.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Reflecting concerns, an analyst from Wells Fargo lowers its rating to Underweight with a new price target of $100. 
&#x2A; An analyst from UBS has decided to maintain their Buy rating on Colgate-Palmolive, which currently sits at a price target of $122. 
&#x2A; An analyst from Piper Sandler has revised its rating downward to Overweight, adjusting the price target to $121. 
&#x2A; Reflecting concerns, an analyst from Deutsche Bank lowers its rating to Hold with a new price target of $109.
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Colgate-Palmolive with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

Check Out What Whales Are Doing With Colgate-Palmolive

Across the recent three months, 12 analysts have shared their insights on CenterPoint Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNP#NYSE">CNP</a>), expressing a variety of opinions spanning from bullish to bearish.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">9</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">5</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
The 12-month price targets, analyzed by analysts, offer insights with an average target of $29.58, a high estimate of $32.00, and a low estimate of $28.00. Experiencing a 4.02% decline, the current average is now lower than the previous average price target of $30.82. 
<img src="https://www.benzinga.com/files/images/story/2024/1727283643_0.png" alt="price target chart" />
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
The perception of CenterPoint Energy by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>David Arcaro</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$32.00</td>
<td>$30.00</td>
</tr>
<tr>
<td>Ross Fowler</td>
<td>B of A Securities</td>
<td>Announces</td>
<td>Neutral</td>
<td>$29.00</td>
<td>-</td>
</tr>
<tr>
<td>James Thalacker</td>
<td>BMO Capital</td>
<td>Maintains</td>
<td>Market Perform</td>
<td>$28.00</td>
<td>$28.00</td>
</tr>
<tr>
<td>Stephen Byrd</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$30.00</td>
<td>$29.00</td>
</tr>
<tr>
<td>Andrew Weisel</td>
<td>Scotiabank</td>
<td>Lowers</td>
<td>Sector Perform</td>
<td>$28.00</td>
<td>$29.00</td>
</tr>
<tr>
<td>Sarah Akers</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$28.00</td>
<td>$32.00</td>
</tr>
<tr>
<td>Jeremy Tonet</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$29.00</td>
<td>$32.00</td>
</tr>
<tr>
<td>James Thalacker</td>
<td>BMO Capital</td>
<td>Lowers</td>
<td>Market Perform</td>
<td>$28.00</td>
<td>$31.00</td>
</tr>
<tr>
<td>James Thalacker</td>
<td>BMO Capital</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$31.00</td>
<td>$32.00</td>
</tr>
<tr>
<td>James Thalacker</td>
<td>BMO Capital</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$32.00</td>
<td>$33.00</td>
</tr>
<tr>
<td>Sophie Karp</td>
<td>Keybanc</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$31.00</td>
<td>$33.00</td>
</tr>
<tr>
<td>Stephen Byrd</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$29.00</td>
<td>$30.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to CenterPoint Energy. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of CenterPoint Energy compared to the broader market.</li>
<li>Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of CenterPoint Energy's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of CenterPoint Energy's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/CNP/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on CenterPoint Energy analyst ratings.</a>
<h2>Discovering CenterPoint Energy: A Closer Look</h2>
CenterPoint Energy owns a portfolio of businesses. Its regulated electric utilities provide transmission and distribution services to more than 2.5 million customers in the Houston area, southern Indiana, and west central Ohio. The company has natural gas distribution systems serving approximately 4 million customers.
<h3>CenterPoint Energy: Financial Performance Dissected</h3>
Market Capitalization Analysis: The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.
Revenue Growth: Over the 3 months period, CenterPoint Energy showcased positive performance, achieving a revenue growth rate of 1.6% as of 30 June, 2024. This reflects a substantial increase in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Utilities sector.
Net Margin: CenterPoint Energy's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 11.97%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): CenterPoint Energy's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 2.24%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 0.56%, the company showcases effective utilization of assets.
Debt Management: CenterPoint Energy's debt-to-equity ratio is below the industry average. With a ratio of 1.85, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings

Demystifying CenterPoint Energy: Insights From 12 Analyst Reviews

Providing a diverse range of perspectives from bullish to bearish, 5 analysts have published ratings on Repay Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RPAY#NASDAQ">RPAY</a>) in the last three months.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
The 12-month price targets, analyzed by analysts, offer insights with an average target of $12.8, a high estimate of $16.00, and a low estimate of $11.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 1.54%. 
<img src="https://www.benzinga.com/files/images/story/2024/1727283636_0.png" alt="price target chart" />
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
The analysis of recent analyst actions sheds light on the perception of Repay Holdings by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Joseph Vafi</td>
<td>Canaccord Genuity</td>
<td>Maintains</td>
<td>Buy</td>
<td>$13.00</td>
<td>$13.00</td>
</tr>
<tr>
<td>Mark Palmer</td>
<td>Benchmark</td>
<td>Maintains</td>
<td>Buy</td>
<td>$13.00</td>
<td>$13.00</td>
</tr>
<tr>
<td>Ramsey El-Assal</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$11.00</td>
<td>$12.00</td>
</tr>
<tr>
<td>Peter Heckmann</td>
<td>DA Davidson</td>
<td>Maintains</td>
<td>Buy</td>
<td>$16.00</td>
<td>$16.00</td>
</tr>
<tr>
<td>Sanjay Sakhrani</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Maintains</td>
<td>Market Perform</td>
<td>$11.00</td>
<td>$11.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Repay Holdings. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Repay Holdings compared to the broader market.</li>
<li>Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
Capture valuable insights into Repay Holdings's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/RPAY/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Repay Holdings analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.
<h2>About Repay Holdings</h2>
Repay Holdings Corp is engaged in providing integrated payment processing solutions to verticals that have transaction processing needs. It allows customers to pay through Mobile App, Text, Interactive Voice Response, Virtual Terminal, Hosted Payment Page and Online Customer Portal among others. It operates in two segment, Consumer Payment and Business Payments.
<h3>Financial Insights: Repay Holdings</h3>
Market Capitalization Analysis: Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.
Revenue Growth: Repay Holdings's revenue growth over a period of 3 months has been noteworthy. As of 30 June, 2024, the company achieved a revenue growth rate of approximately 4.35%. This indicates a substantial increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Financials sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of -5.43%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): Repay Holdings's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive -0.5% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): Repay Holdings's ROA excels beyond industry benchmarks, reaching -0.27%. This signifies efficient management of assets and strong financial health.
Debt Management: With a below-average debt-to-equity ratio of 0.54, Repay Holdings adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>Analyst Ratings: Simplified</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

RPAY

A Closer Look at 5 Analyst Recommendations For Repay Holdings

Ulta Beauty (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ULTA#NASDAQ">ULTA</a>) has outperformed the market over the past 15 years by 11.9% on an annualized basis producing an average annual return of 23.93%. Currently, Ulta Beauty has a market capitalization of $18.88 billion. 
Buying $100 In ULTA: If an investor had bought $100 of ULTA stock 15 years ago, it would be worth $2,426.86 today based on a price of $400.68 for ULTA at the time of writing.
<h3>Ulta Beauty's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1727283628_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ULTA

If You Invested $100 In This Stock 15 Years Ago, You Would Have $2,400 Today

Insight Enterprises (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NSIT#NASDAQ">NSIT</a>) has outperformed the market over the past 20 years by 4.68% on an annualized basis producing an average annual return of 13.07%. Currently, Insight Enterprises has a market capitalization of $6.91 billion. 
Buying $100 In NSIT: If an investor had bought $100 of NSIT stock 20 years ago, it would be worth $1,174.12 today based on a price of $211.99 for NSIT at the time of writing.
<h3>Insight Enterprises's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1727283624_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

NSIT

If You Invested $100 In This Stock 20 Years Ago, You Would Have $1,200 Today

Guggenheim analyst Gregory Francfort maintains Texas Roadhouse (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TXRH#NASDAQ">TXRH</a>) with a Buy and raises the price target from $190 to $195.

Price Target

TXRH

Guggenheim Maintains Buy on Texas Roadhouse, Raises Price Target to $195

Ratings for bluebird bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLUE#NASDAQ">BLUE</a>) were provided by 5 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $3.8, a high estimate of $6.00, and a low estimate of $2.00. A decline of 26.92% from the prior average price target is evident in the current average. 
<img src="https://www.benzinga.com/files/images/story/2024/1727283614_0.png" alt="price target chart" />
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
The analysis of recent analyst actions sheds light on the perception of bluebird bio by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Yanan Zhu</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$2.00</td>
<td>$3.00</td>
</tr>
<tr>
<td>Jason Gerberry</td>
<td>B of A Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$3.00</td>
<td>$4.00</td>
</tr>
<tr>
<td>Luca Issi</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Sector Perform</td>
<td>$4.00</td>
<td>$4.00</td>
</tr>
<tr>
<td>Gena Wang</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$4.00</td>
<td>$8.00</td>
</tr>
<tr>
<td>Jack Allen</td>
<td>Baird</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$6.00</td>
<td>$7.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to bluebird bio. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of bluebird bio compared to the broader market.</li>
<li>Price Targets: Gaining insights, analysts provide estimates for the future value of bluebird bio's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
For valuable insights into bluebird bio's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/BLUE/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on bluebird bio analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.
<h2>Get to Know bluebird bio Better</h2>
bluebird bio Inc is a biotechnology company engaged in researching, developing, and commercializing potentially curative gene therapies for severe genetic diseases based on its proprietary lentiviral vector (LVV) gene addition platform. The Company operates in a single segment, focusing on researching, developing and commercializing potentially transformative gene therapies for severe genetic diseases.
<h3>Financial Milestones: bluebird bio's Journey</h3>
Market Capitalization Highlights: Above the industry average, the company's market capitalization signifies a significant scale, indicating strong confidence and market prominence.
Positive Revenue Trend: Examining bluebird bio's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 680.05% as of 31 March, 2024, showcasing a substantial increase in top-line earnings. When compared to others in the Health Care sector, the company excelled with a growth rate higher than the average among peers.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of -375.84%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): bluebird bio's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of -42.88%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): bluebird bio's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of -11.16%, the company may face hurdles in generating optimal returns from its assets.
Debt Management: bluebird bio's debt-to-equity ratio surpasses industry norms, standing at 3.16. This suggests the company carries a substantial amount of debt, posing potential financial challenges.
<h2>The Significance of Analyst Ratings Explained</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BLUE

The Analyst Verdict: bluebird bio In The Eyes Of 5 Experts

Macro Notification

General

Russia's Putin Says Russia Would Consider Using Nuclear Weapons If It Gets Reliable Information About Start Of Mass Cross-Border Attack By Air From Strategic And Tactical Aviation, Cruise Missiles, Drones And Hypersonic Weapons

DraftKings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DKNG#NASDAQ">DKNG</a>) shares are rising, likely in sympathy with Flutter Entertainment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLUT#NYSE">FLUT</a>), which saw a boost after issuing <a target="_blank" href="https://www.benzinga.com/movers" rel="noreferrer noopener">positive guidance for 2027.</a>
As both companies operate in the online sports betting and iGaming sector, Flutter&#8217;s optimistic outlook appears to be creating a ripple effect, lifting DraftKings&#8217; share movement as investors react to the <a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">overall market sentiment.</a>
Flutter targets revenue of around $21 billion in 2027, representing a compound annual growth rate (CAGR) of 14%, based on the midpoint of U.S. and Rest of World (ROW) 2027&nbsp;guidance.
Also, Flutter projects an adjusted EBITDA of over $5 billion, adjusted EBITDA&nbsp;margin expansion of 700 basis points, and free cash flow of around $2.5 billion by 2027.
Apart from this, Flutter approved a share buyback program of up to $5 billion, set to be implemented over the next three to four years, with a launch anticipated after the third-quarter earnings report in November 2024.
Also Read: <a target="_blank" href="https://www.benzinga.com/markets/equities/24/09/41028246/flutter-bets-big-on-us-and-global-expansion-21b-revenue-goal-and-5b-buyback-in-sight" rel="noreferrer noopener">Flutter Bets Big On US And Global Expansion: $21B Revenue Goal And $5B Buyback In Sight</a>
The significant total addressable market (TAM) for regulated gaming is projected to reach $368 billion by 2030, with global gross gaming revenue (GGR) expected to grow at a compound annual growth rate (CAGR) of 8%.
According to&nbsp;<a target="_blank" href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw" rel="noreferrer noopener">Benzinga Pro</a>, DKNG stock has gained over 52% in the past year. Investors can gain exposure to the stock via&nbsp;Roundhill Sports Betting &amp; iGaming ETF (BETZ) and&nbsp;Pacer BlueStar Digital Entertainment ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ODDS#NASDAQ">ODDS</a>).
As the online sports betting market continues to evolve, DraftKings stands to benefit from Flutter&#8217;s optimistic projections and overall market growth, positioning both companies for potential success in the coming years.
DKNG, FLUT Price Actions: DraftKings shares are trading higher by 6.49% to $41.68. Flutter shares are trading higher by 6.53% at $243.07.
Photo via Shutterstock
Read Next:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/08/40446628/draftkings-vs-flutter-analyst-lays-out-bull-vs-bear-debate-with-sports-betting-mark" target="_blank" rel="noreferrer noopener">DraftKings Vs. Flutter: Analyst Lays Out Bull Vs. Bear Debate With Sports Betting Market &#8216;Increasingly Functioning As A Duopoly&#8217;</a></li>
</ul>

Equities

DKNG

FLUT

ODDS

Why Is DraftKings Stock Gaining Today?

Sony Group Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SONY#NYSE">SONY</a>) has unveiled the PlayStation Plus lineup for October, bringing an exciting mix of <a href="https://www.benzinga.com/general/gaming">games to subscribers.</a>
Available from Oct. 1 through Nov. 4, this month&#8217;s <a href="https://blog.playstation.com/2024/09/24/playstation-plus-monthly-games-for-october-wwe-2k24-dead-space-doki-doki-literature-club-plus/#:~:text=PlayStation%20Plus%20Monthly%20Games%20for,%E2%80%93%20PlayStation.Blog">offerings </a>range from sports action to survival horror and indie favorites.
See Also: <a href="https://www.benzinga.com/general/gaming/24/09/40985116/playstation-30th-anniversary-ps5-slim-bundle-price-revealed-heres-what-itll-cost-you">PlayStation 30th Anniversary PS5 Slim Bundle Price Revealed: Here&#8217;s What It&#8217;ll Cost You</a>
Here's a breakdown of what to expect:
<ul>
<li>WWE 2K24 (PS4, PS5) The latest entry in the popular wrestling series, WWE 2K24, comes with refined mechanics and improved visuals. </li>
<li>Dead Space Remake (PS5) This highly-praised remake of the 2008 survival horror classic earned a 9/10 from IGN. Fans of atmospheric horror will not want to miss this updated version.</li>
<li>Doki Doki Literature Club (PS4, PS5) Don&#8217;t let the cute visuals fool you—this game takes a dark turn into psychological horror. Originally launched on PC in 2017, it's since become an indie darling and was a top seller on the Nintendo Switch. PlayStation fans can now experience its unique blend of visual novel storytelling and horror twists.</li>
</ul>
<h3 class="wp-block-heading">PlayStation Classics</h3>
In addition to the monthly lineup, PlayStation announced that two iconic titles are coming to the PlayStation Classics Catalog soon:
<ul>
<li>Blood Omen: Legacy of Kain</li>
<li>Dino Crisis</li>
</ul>
These classic PlayStation titles will be available to PS Plus Premium subscribers, offering a nostalgic throwback for long-time PlayStation fans.
<h3 class="wp-block-heading">Celebrate The Last Of Us Day</h3>
To mark The Last of Us Day on Sept. 26, The Last of Us Part 1 will be added to the PS Plus catalog for Premium and Extra members, giving more players a chance to experience this award-winning title.
<h3 class="wp-block-heading">Last Call For September's Games</h3>
Don't forget: you have until Sept. 30 to pick up this month&#8217;s PS Plus games, which include:
<ul>
<li>Harry Potter: Quidditch Champions</li>
<li>MLB The Show 24</li>
<li>Little Nightmares 2</li>
</ul>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/gaming/24/09/40883757/sony-ceo-confirms-consoles-are-still-core-to-playstations-future">Sony CEO Confirms Consoles Are Still &#8216;Core&#8217; To PlayStation&#8217;s Future</a></li>
</ul>
Image credits: Shutterstock.

Gaming

SONY

PlayStation Plus October Lineup Revealed: WWE 2K24, Dead Space, More

Renowned macro analyst Lyn Alden released a comprehensive study exploring Bitcoin's (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) role as a global liquidity barometer, revealing its unique sensitivity to monetary conditions and potential as <a href="https://www.benzinga.com/money/bitcoin-price-prediction">an investment tool</a>.
What Happened: The research, conducted by Sam Callahan under Alden&#8217;s guidance, finds that Bitcoin moves in the same direction as global liquidity 83% of the time over 12-month periods &#8211; a higher correlation than any other major asset class. This strong relationship positions Bitcoin as a &#8220;liquidity barometer&#8221; that reflects changes in the global money supply and dollar strength.
Bitcoin As Liquidity Indicator
Callahan explains that Bitcoin&#8217;s purity as a liquidity indicator stems from its lack of confounding factors like earnings or dividends that influence stocks. Unlike gold or bonds, Bitcoin is still widely viewed as a risk asset at this stage of adoption, further tightening its link to liquidity conditions.
However, the study notes that Bitcoin&#8217;s correlation can break down over shorter timeframes or during periods of extreme valuation. By combining liquidity analysis with on-chain metrics like the MVRV Z-score, investors can better identify when Bitcoin may temporarily decouple from broader trends.
The research suggests Bitcoin offers a highly sensitive vehicle for expressing views on global liquidity. As Callahan states, &#8220;When Bitcoin&#8217;s sirens ring, investors would be wise to listen so that they can manage risk and position themselves appropriately to capitalize on future opportunities in the market.&#8221;
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/events/digital-assets/ "><img loading="lazy" decoding="async" width="300" height="250" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/03/29155259/905735A6-57D3-4874-9AA1-75D037842DB3-2.gif" alt="Benzinga Future of Digital Assets conference" class="wp-image-270548" /></a></figure>
Liquidity Correlation To Stocks, Bonds, Gold
For long-term holders, understanding this liquidity relationship provides deeper insight into Bitcoin&#8217;s price drivers. Traders may find Bitcoin an attractive option for implementing macro liquidity strategies.
The study also compares Bitcoin&#8217;s liquidity correlation to other assets like stocks, bonds, and gold. While equities showed strong relationships, Bitcoin demonstrated the highest directional consistency with liquidity trends.
What&#8217;s Next: Alden&#8217;s analysis comes as investors increasingly grapple with liquidity-driven markets in the post-2008 era. By quantifying Bitcoin&#8217;s role as a liquidity gauge, the research offers a valuable framework for navigating an asset still considered enigmatic by many traditional analysts.
The influence of&nbsp;<a href="https://www.benzinga.com/money/is-bitcoin-a-good-investment" target="_blank" rel="noreferrer noopener">Bitcoin as an institutional asset class</a>&nbsp;is expected to be thoroughly explored at Benzinga&#8217;s upcoming&nbsp;<a href="https://www.benzinga.com/events/digital-assets/agenda/" target="_blank" rel="noreferrer noopener">Future of Digital Assets</a>&nbsp;event on Nov. 19.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/09/40989892/bitcoins-22-rally-isnt-enough-it-must-break-august-high-to-overcome-downtrend-bitfinex-ana">Bitcoin&#8217;s 22% Rally Isn&#8217;t Enough, It Must Break August High To Overcome Downtrend, Bitfinex Analysts Say</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

Bitcoin As 'Global Liquidity Barometer:' This Relationship Holds 83% Of The Time Over 12-Month Periods

- Reuters&nbsp;
- Reuters&nbsp;

Russia's Putin Says Aggression Against Russia By Any Non-Nuclear State, But With The Participation Or Support Of A Nuclear State, Is Proposed To Be Considered As Their Joint Attack On The Russian Federation; We Reserve The Right To Use Nuclear Weapons In Case Of Aggression Against Russia and Belarus Including If The Enemy Poses A Critical Threat To Our Sovereignty With Conventional Weapons

Mizuho analyst David Bellinger maintains AutoZone (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AZO#NYSE">AZO</a>) with a Outperform and raises the price target from $3280 to $3350.

Mizuho Maintains Outperform on AutoZone, Raises Price Target to $3350

Russia's Putin Says Number Of Clarifications Have Been Proposed With Regard To Definition Of Conditions For Use Of Nuclear Weapons; Current Military-Political Situation Is Changing Dynamically In The World, And We Must Take This Into Account; We See The Emergence Of New Sources Of Military Threats And Risks For Russia And Our Allies; Category Of States And Military Alliances Subject To Nuclear Deterrence Has Been Expanded

<a href="https://www.rubrik.com/blog/technology/24/9/user-intelligence-government">https://www.rubrik.com/blog/technology/24/9/user-intelligence-government</a>
We're thrilled to announce the availability of User Intelligence on <a href="https://www.rubrik.com/blog/technology/24/9/products">Rubrik Security Cloud</a> - Government. Rubrik User Intelligence empowers Fed and SLED organizations with visibility into user activities, access patterns, and potential risks. This level of insight is critical for enforcing least-privilege access to sensitive data, before it results in breaches.
For Federal and State/Local Governments, understanding who has access to sensitive data and how it's being used is crucial for maintaining data integrity, ensuring compliance, and swiftly responding to security incidents.
Generally, the process of enforcing user access becomes fluid and chaotic as data continues to proliferate across various platforms and environments. People move in and out of the company, move horizontally within the organization, and configuration drift occurs—leaving access to this sensitive information wide open to users and groups that don't need it.&nbsp;
Organizations need to first understand exactly who has access to sensitive information and how that access has changed over time. Only then can the company take proactive actions to enforce least privileged access.
<h2>Introducing User Intelligence for Rubrik Security Cloud - Government</h2>
With the addition of User Intelligence to Rubrik Security Cloud - Government, agencies can:
Gain User Access Visibility: Obtain a holistic view of user access patterns and behaviors across the environment.
Streamline Reporting: Easily generate reports on user access and activities to support audit requirements and demonstrate that your data is secure.
Enhance Access Control: Use granular insights to refine and optimize access policies, ensuring the principle of least privilege is enforced and maintained.
Accelerate Incident Response: Quickly investigate and respond to potential security incidents with detailed user activity timelines and analysis.
In addition to pointing out who has access to sensitive information and bubbling up risk analysis and exposure, User Intelligence also reports on how that access has changed over time.
It enables proactive data exposure risk reduction by providing visibility into sensitive data access, calculating risk, and tracking changes to the data and associated risk over time. The entire process of scanning for sensitive data and determining user access happens on backup data, essentially, the catalog of your entire environment - no heavy-duty agents, no impact on production.
<h2>Government Certifications</h2>
Rubrik Security Cloud - Government continues to meet rigorous security standards, including StateRAMP&#x2122; certification, "In Process" FedRAMP&#xAE; Moderate status, and security attestations for CJIS Security Policy and FERPA security conformance.
Hundreds of state and local governments nationwide already rely on Rubrik to secure their critical data. With the addition of User Intelligence, Rubrik further solidifies its commitment to providing government entities with the tools they need to protect sensitive information and maintain operational resilience in the face of evolving cyber threats.

RBRK

'How Government Agencies Can Regain Control Over Who Has Access to Sensitive Public Data; Rubrik Announces The Availability Of User Intelligence On Rubrik Security Cloud - Government' - Blog Post

Stellantis (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STLA#NYSE">STLA</a>) and China&#8217;s Leapmotor revealed that they are set to begin taking orders in Europe for a city car and an SUV, as they expand their budget electric vehicle (EV) offerings in the region.
Stellantis is leading a 51:49 operating agreement for the joint venture Leapmotor International, as the Leapmotor C10 and T03 media <a target="_blank" href="https://www.media.stellantis.com/em-en/leapmotor/press/leapmotor-international-s-first-european-media-drive-in-milan?adobe_mc_ref=" rel="noreferrer noopener">event </a>takes place in Milan.
This strategic partnership aims to accelerate and boost Leapmotor&#8217;s product sales globally, excluding Greater China, by leveraging Stellantis&#8217; global resources and commercial expertise to offer affordable prices.
Earlier this week, the company was in the headlines after it confirmed that it is looking for a new CEO to replace&nbsp;Carlos Tavares.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/24/09/40998923/stellantis-begins-search-for-new-ceo-to-succeed-carlos-tavares-report" rel="noreferrer noopener">Stellantis Begins Search For New CEO To Succeed Carlos Tavares (Updated)</a>
Tavares took the helm of the company in January 2021. The search for a new CEO is part of the normal process of determining leadership succession &#8220;given the importance of the position,&#8221; a Stellantis media representative&nbsp;told&nbsp;<a target="_blank" href="https://pro.benzinga.com/dashboard" rel="noreferrer noopener">Benzinga</a> in a statement.
Tavares&#8217; contract is set to expire in 2026. The company added that there is still a possibility that the current CEO will stay in the role for longer.
Earlier this month, President of U.S. Stellantis National Dealer Council (NDC)&nbsp;Kevin Farrish&nbsp;reportedly <a target="_blank" href="https://www.benzinga.com/news/24/09/40827607/stellantis-fires-back-at-us-dealer-councils-allegation-of-short-term-decision-making-carmaker-says-p" rel="noreferrer noopener">wrote to company CEO</a> Tavares, accusing him of &#8220;short-term decision-making&#8221; and urged that the CEO spend more to clear older inventory.
Meanwhile, the carmaker&nbsp;Stellantis reportedly responded that it takes &#8220;absolute exception&#8221; to the open letter sent by the Farrish, terming it a &#8220;public personal attack.&#8221;
Price Action: STLA shares are trading lower by 1.70% to $15.30 at last check Wednesday.
Photo by Jonathan Weiss on Shutterstock
Read Next:
<ul>
<li><a href="https://www.benzinga.com//node/40996517" target="_blank" rel="noreferrer noopener">Stellantis Denies UAW Allegations Of Failing To Keep Promises Made To Workers</a></li>
</ul>

STLA

Stellantis And Leapmotor Gear Up For European Launch Of Budget City Car And SUV

Choice Hotels International, Inc.&#39;s (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/chh#NYSE">CHH</a>) expertise in top-tier hotel conversions is opening new doors for it in the extended-stay hotels segment along with expanding its market reach.
Between Jan. 1 and Sept. 17, 2024, CHH opened 17 MainStay Suites and Suburban Studios hotels, of which 16 properties were conversions, with the average length of time between contract signing and official opening being around 120 days. The key opening markets were Las Vegas, NV; Moreno Valley, CA; Orlando and Tampa, FL.
Furthermore, about half of the approximately 70 properties in the pipeline for MainStay Suites and Suburban Studios are conversions, which are expected to open between September 2024 and March 2025.
CHH stock inched up 0.5% during the trading hours on Monday following this announcement.
<h2>CHH&#39;s MainStay Suites &amp; Suburban Studios</h2>
Two of Choice Hotels&#39; proprietary brand names, MainStay Suites and Suburban Studios, offer the comforts of home with a fully equipped kitchen in every room housing almost all the necessary kitchen appliances. Guests can unwind and relax or catch up on work with free Wi-Fi in the spacious guestrooms.
The guest profile of MainStay Suites comprises sports teams, medical professionals, business travelers, members of the military, mid-level blue-collar workers, students, professors, medical patients and people relocating or renovating their homes. On the other hand, the guest profile of Suburban Studios includes blue-collar infrastructure and construction workers as well as seasonal workers and families.
<h2>Choice Hotels&#39; Extended-Stay Conversion Success</h2>
Choice Hotels&#39; move into the extended-stay hotel space has been gaining recognition in the industry. The imbalance between low supply and high demand for extended-stay hotels has been fueling the growth trend of this business in the hospitality industry.
The company&#39;s success in this space is built upon its &quot;Kitchen-in-a-Box&quot; concept, which showcases a modular kitchen design that allows franchisees to quickly and efficiently convert a transient hotel into an extended-stay hotel with kitchens in each room. With a conversion tenure of three to four months, with this model, owners and developers can make expeditious offerings of extended stay rooms.
During the second quarter of 2024, CHH grew its domestic extended-stay unit system size by 14% year over year. With growth across its extended-stay brands&#39; portfolio, the company is well-positioned to achieve a long-term average annual growth of 15%.
<h2>CHH&#39;s Price Performance</h2>
Shares of this global hotel franchisor have gained 15.3% in the year-to-date period, outperforming the Zacks Hotels and Motels industry&#39;s 11.6% growth.&nbsp; Strong demand trends across the company&#39;s diversified portfolio of brands and extended-stay conversion hotel openings, along with international market reach expansion, are favoring the growth trajectory.
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/f0/78995.jpg?v=845945776" />
Image Source: Zacks Investment Research
The improving trend is clear from CHH&#39;s estimate revision trend as well. The Zacks Consensus Estimate for third-quarter 2024 earnings per share has trended upward to $1.93 from $1.91 in the past 30 days. The estimated figure indicates 6% year-over-year growth.
<h2>CHH&#39;s Zacks Rank &amp; Key Picks</h2>
Choice Hotels currently carries a Zacks Rank #3 (Hold).
Here are some better-ranked stocks from the Consumer Discretionary sector.
Interface, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tile#NASDAQ">TILE</a>) currently sports a Zacks Rank #1 (Strong Buy).
TILE has a trailing four-quarter earnings surprise of 65%, on average. The stock has surged 88.7% in the past year. The Zacks Consensus Estimate for TILE&#39;s 2024 sales and earnings per share indicates growth of 3.9% and 28%, respectively, from the year-ago levels.
DoubleDown Interactive Co., Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ddi#NASDAQ">DDI</a>) currently sports a Zacks Rank of 1. DDI has a trailing four-quarter earnings surprise of 22.1%, on average. The stock has gained 54% in the past year.
The Zacks Consensus Estimate for DDI&#39;s 2024 sales and EPS indicates an increase of 12.6% and 15.8%, respectively, from the year-ago levels.
Norwegian Cruise Line Holdings Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nclh#NYSE">NCLH</a>) presently sports a Zacks Rank of 1. NCLH has a trailing four-quarter earnings surprise of 5.7%, on average. The stock has gained 38.3% in the past year.
The Zacks Consensus Estimate for NCLH&#39;s 2024 sales and EPS indicates an increase of 9.8% and 125.7%, respectively, from the year-ago levels.
<a href="https://www.zacks.com/stock/news/2340767/chh-emerges-as-the-pioneer-of-extended-stay-conversion-hotels?cid=CS-BENZ-FT-analyst_blog|company_news_corporate_actions-2340767">To read this article on Zacks.com click here.</a>

Earnings

Mid Cap

Small Cap

NCLH

TILE

CHH Emerges as the Pioneer of Extended-Stay Conversion Hotels

Daniel Lubetzky, the founder of KIND Snacks, is <a href="https://www.benzinga.com/general/entertainment/24/09/40930343/slide-over-mark-cuban-theres-a-new-shark-in-the-pool-could-this-billionaire-be-his-replacem">joining the panel of regular sharks</a> on &#8220;Shark Tank&#8221; replacing <a href="https://www.benzinga.com/topic/mark-cuban">Mark Cuban</a>. But before becoming a business mogul, Lubetzky made a risky $220 million move that almost cost him his company. It turned out to be the best decision he ever made.
Back in 2008, KIND was still a small player in the snack industry. Lubetzky had just taken a $16 million investment from a private equity firm, VMG Partners. The deal was that he had to sell the company within five years. It seemed like a solid plan then but things turned unexpectedly.
Don't Miss:
<ul>
<li>A billion-dollar investment strategy with minimums as low as $10 —<a href="https://www.benzinga.com/money/fundrise-flagship-fund"> you can become part of the next big real estate boom today.</a></li>
<li>Amid the ongoing EV revolution, previously overlooked low-income communities<a href="https://www.benzinga.com/money/dunamis-1"> now harbor a huge investment opportunity at just $500.</a></li>
<li>Will the surge continue or decline on real estate prices? <a href="https://www.benzinga.com/money/realbricks" target="_blank" rel="noreferrer noopener">People are finding out about risk-free real estate investing that lets you cash out whenever you want.</a></li>
</ul>
&#8220;Four years into the deal, I was realizing that Kind could become so much bigger,&#8221; he recalled to CNBC. Sales were up and Lubetzky felt the company had much more potential. But his investors were eager to cash out, pressuring him to sell. Instead of giving in, Lubetzky decided to buy back their shares. The problem was, he needed $220 million to do it.
<h2 class="wp-block-heading">The Gamble of a Lifetime</h2>
This was no small feat. Lubetzky had to scrape together company cash and take on millions in bank loans to make it happen. &#8220;Because I hadn't pre-negotiated the terms for buying them out, it turned out to be very, very expensive – and very risky. It was a very painful negotiation,&#8221; he said.&nbsp;
<hr class="wp-block-separator has-alpha-channel-opacity" />
Trending: Unlock the hidden potential of commercial real estate —<a href="https://www.benzinga.com/money/marcus-millichap-backed-platform-makes-it-easy-to-invest-in-real-estate"> This platform allows individuals to invest in commercial real estate offering a 12% target yield with a bonus 1% return boost today!</a>
<hr class="wp-block-separator has-alpha-channel-opacity" />
He could have lost everything if KIND's sales had dropped even slightly. He had sleepless nights knowing that any misstep could result in losing the company he'd built from scratch.
But Lubetzky believed in KIND and decided to leap. &#8220;I felt like we were just getting started,&#8221; he said. He was right. The company's annual sales nearly doubled that year, setting the stage for what would come next.
Lubetzky transformed his $220 million gamble into a tremendous win. By the time he decided to sell KIND to Mars in 2020, the firm had amassed an astounding $5 billion valuation. He attributes KIND&#8217;s success to his decision to purchase back his company.
<hr class="wp-block-separator has-alpha-channel-opacity" />
Trending: This investment company boasts a 35.14% internal rate of return (IRR) for its realized projects, allowing accredited investors to<a href="https://www.benzinga.com/money/bam-capital"> earn passive returns and avoid the headaches of being a landlord.</a>
<hr class="wp-block-separator has-alpha-channel-opacity" />
&#8220;If we had sold back in 2013, KIND might have gotten lost inside a big corporation,&#8221; he explained. Instead, he kept the company independent and, as a result, it grew into one of the world&#8217;s most recognized healthy snack brands.
He wishes he knew back then that when you negotiate with a private equity firm, it's not &#8220;their way or the highway.&#8221; When you <a href="https://www.benzinga.com/partner/movers-shakers/24/07/39904273/interested-in-investing-in-private-companies-like-openai-but-dont-have-the-capital-check-o">bring investors into your company</a>, it's no longer completely yours. &#8220;You need to remember that it's now a company that you and others own,&#8221; Lubetzky shares.
As the new regular on &#8220;Shark Tank,&#8221; Lubetzky will bring this same boldness and entrepreneurial spirit to the show.&nbsp;
See Also: Founder of Personal Capital and ex-CEO of PayPal<a href="https://www.benzinga.com/money/evergreen-money"> re-engineers traditional banking with this new high-yield account — start saving better today.</a>
<h2 class="wp-block-heading">Why Mark Cuban Left</h2>
After more than 10 years as a regular on the program, <a href="https://www.benzinga.com/news/23/11/35988212/mark-cuban-to-exit-shark-tank-reflects-on-his-worst-deal-and-surprise-success-shared-with-benzinga">Mark Cuban decided to leave &#8220;Shark Tank&#8221;</a> in order to spend more time with his family. Having balanced business endeavors and TV appearances for years, he now desired to devote himself to spending more time with his wife and three kids before they left to pursue their own lives.
Read Next:
<ul>
<li>This Jeff Bezos-backed startup will allow you to<a href="https://www.benzinga.com/money/bezos-landlord-100-dollars"> become a landlord in just 10 minutes, and you only need $100</a>.</li>
<li>These five entrepreneurs are worth $223 billion –<a href="https://www.benzinga.com/money/arrived-homes-private-credit-fund"> they all believe in one platform that offers a 7-9% target yield with monthly dividends</a></li>
</ul>

Startups

The New Shark Tank Star Replacing Mark Cuban Once Made A $220 Million Blunder That Grew His Startup Into A $5 Billion Powerhouse

Analyst Emily Bodnar from H.C. Wainwright maintained a Buy rating on Jasper Therapeutics (JSPR – Research Report) and keeping the price target at $...

Optimistic Outlook: Jasper Therapeutics' Clinical Advances and Market Potential

Analyst Tim Chiang of Capital One Financial assigned a Buy rating on Jasper Therapeutics (JSPR – Research Report), retaining the price target of $5...

Buy Rating for Jasper Therapeutics: Clinical Progress and Financial Stability Signal Strong Potential

TD Cowen analyst Yaron Werber has maintained their bullish stance on JSPR stock, giving a Buy rating today. Yaron Werber has given his Buy rating d...

Optimistic Buy Rating for Jasper Therapeutics as Briquilimab Shows Promising Trial Progress

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Jasper Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/jspr-stock-quote/">JSPR</a>) just reported results for the second quarter of 2024.<ul><li>Jasper Therapeutics reported earnings per share of -97 cents. This was above the analyst estimate for EPS of -$1.09.</li><li>The company did not report any revenue for the quarter.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/earning-results/2024/08/jspr-stock-earnings-jasper-therapeutics-for-q2-of-2024/">JSPR Stock Earnings: Jasper Therapeutics Beats EPS for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

JSPR Stock Earnings: Jasper Therapeutics Beats EPS for Q2 2024

BTIG analyst Justin Zelin has reiterated their bullish stance on JSPR stock, giving a Buy rating yesterday. Justin Zelin has given his Buy rating d...

Buy Rating Reaffirmed for Jasper Therapeutics on Strong Clinical Performance and Market Potential

In a report released yesterday, Gregory Renza from RBC Capital maintained a Buy rating on Jasper Therapeutics (JSPR – Research Report), with a pric...

RBC Capital Keeps Their Buy Rating on Jasper Therapeutics (JSPR)

Oppenheimer analyst Jay Olson maintained a Buy rating on Jasper Therapeutics (JSPR – Research Report) today and set a price target of $80.00. The c...

Oppenheimer Sticks to Their Buy Rating for Jasper Therapeutics (JSPR)

In a report released on August 16, Benjamin Burnett from Stifel Nicolaus maintained a Buy rating on Jasper Therapeutics (JSPR – Research Report). T...

Jasper Therapeutics (JSPR) Gets a Buy from Stifel Nicolaus

Silvan Tuerkcan, an analyst from JMP Securities, has initiated a new Buy rating on Jasper Therapeutics (JSPR). Silvan Tuerkcan has given his Buy ra...

Buy Rating Justified by Jasper Therapeutics' Innovative c-Kit Targeting Treatments and Market Potential

Tim Chiang, an analyst from Capital One Financial, assigned the Buy rating on Jasper Therapeutics (JSPR – Research Report). The associated price ta...

Top Stock Ideas Sent Daily — Join and Gain Your Edge

Top Stock Ideas Sent Daily — Join and Gain Your Edge

Comments

Jasper Therapeutics

Jasper Therapeutics (JSPR) Forecast

Jasper Therapeutics (NASDAQ:JSPR) Stock, Quote.Headers.trade-ideas